A new approach to combatting Lyme disease is on the horizon. A team of researchers at the University of California San Diego (UCSD) have developed a novel antibiotic drug candidate that could provide a more effective treatment for the disease. The drug candidate, known as LP30, works by targeting a critical enzyme in the Lyme bacterium, Borrelia burgdorferi, which helps it to survive. In laboratory studies, the drug was found to be up to 90 percent effective in killing the Lyme bacterium. This is a promising result, as current antibiotics used to treat Lyme disease have limited success in eliminating the infection. The researchers believe that this new drug candidate could be a much more effective treatment for the disease, and could help reduce the number of people suffering from Lyme disease each year.

Read Full Article Here

source: Phys.org